🔎 Trials Near Me

Home › HPV › NCT06598475

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Recruiting

Who can join

Ages 11 to 17 · All sexes

Full eligibility criteria
Inclusion Criteria:

* FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites
* FQHC's that have family medicine and/or pediatric practices
* a total adolescent patient population at least 50% Latino
* be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree to randomization.
* Providers, aged 18 and over, employed at each FQHC (4 staff per practice)
* Staff, aged 18 and over, employed at each FQHC (5 staff per practice)
* Implementation team members (i.e., administrative designee, health care providers, immunization navigators, and other staff), aged 18 and over, employed at each FQHC (4 members per practice)
* Parents (aged 18 and over) of patients ages 11-17 seeking care at each FQHC (25 per practice).

Exclusion Criteria:

-FQHCs that participated in the pilot study were excluded.

About the study

The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites

What is being tested

Sponsor: The University of Texas Health Science Center, Houston · Participants: 225 · Started: Mar 13, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06598475

Locations in the U.S.

TexasThe University of Texas Health Science Center at Houston, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.